Posts

, ,

Saving Lives: Malaria Prevention in Sub-Saharan Africa

Malaria Prevention in Sub-Saharan AfricaMalaria prevention in sub-Saharan Africa remains a critical global health priority. Despite significant progress over the past two decades, malaria continues to affect countries across the region disproportionately. Expanding prevention efforts is essential to saving lives, strengthening economies and reducing poverty.

The Scale of the Problem

According to the World Health Organization (WHO), there were approximately 282 million malaria cases globally in 2024, with sub-Saharan Africa accounting for about 95% of cases and deaths. The region recorded more than 600,000 malaria-related deaths, with children under 5 representing about 76% of those fatalities. Countries such as Nigeria, the Democratic Republic of the Congo, Uganda and Mozambique carry some of the heaviest burdens.

Rural communities are especially vulnerable due to limited access to health care facilities and preventive tools.

Impact on Education and Economic Stability

Malaria prevention in sub-Saharan Africa is not only a health issue but also an economic one. Frequent illness leads to missed school days for children and lost wages for adults. In high-transmission areas, students may miss several weeks of school each year due to illness or caring for sick family members. Repeated absences can reduce academic performance and long-term educational outcomes.

For adults, malaria decreases workforce productivity. Farmers may be unable to tend crops during peak agricultural seasons and small business owners may lose income due to illness. Health care costs, transportation to clinics and lost workdays push many households deeper into poverty.

In some communities, families must borrow money or sell assets to pay for treatment, creating long-term financial strain. Fortunately, significant progress has been made through coordinated prevention strategies. Insecticide-treated nets (ITNs), indoor residual spraying and rapid diagnostic testing have helped reduce transmission rates in many countries.

Recently, malaria vaccines have also been introduced in select African nations, offering additional protection for young children.

Organizations Combating Malaria in Sub-Saharan Africa

  • The Global Fund: It provides funding to countries to strengthen prevention, treatment and health systems. Since its founding, the Global Fund has supported the distribution of hundreds of millions of ITNs and funded malaria treatment programs across dozens of African countries. In 2024 alone, the organization distributed more than 160 million mosquito nets worldwide.
  • UNICEF: This nonprofit works closely with governments to protect children from malaria. The organization supports seasonal malaria prevention programs, distributes bed nets and improves access to testing and treatment in remote areas. UNICEF has helped deliver millions of doses of preventive medicine to children in high-risk countries such as Nigeria and Chad.
  • The President’s Malaria Initiative: This Initiative operates in more than 20 African countries. It supports indoor spraying campaigns, distributes millions of bed nets annually and strengthens local health systems. The Initiative has contributed to significant reductions in malaria mortality rates in several partner countries since its launch.

Final Remarks

Malaria prevention in sub-Saharan Africa is directly linked to poverty reduction, educational advancement and economic stability. By protecting vulnerable populations, especially young children, these efforts help communities build healthier and more productive futures. Continued global commitment and coordinated action are necessary to reduce malaria cases further and move closer to elimination.

– Nishanth Pothapragada

Nishanth is based in London, Ontario, Canada and focuses on Global Health for The Borgen Project.

Photo: Flickr

, ,

Sustained Funding & Combating HIV/AIDS in Comoros

HIV/AIDS in ComorosLimited health care infrastructure, economic vulnerability and heavy reliance on external humanitarian aid make the fight against HIV/AIDS in Comoros fragile. While HIV prevalence remains low, progress depends largely on donor-funded programs. Inconsistent and short-term funding threatens to reverse gains in prevention, treatment access and health system resilience. Sustained funding for HIV/AIDS in Comoros is essential to ensure long-term prevention, uninterrupted treatment and national health stability.

HIV/AIDS in Comoros: A Fragile Success

HIV prevalence in Comoros remains below 1%, one of the lowest rates in sub-Saharan Africa. This success is largely due to early prevention strategies, cultural factors and donor-supported health programs. However, limited domestic health financing means that HIV/AIDS services depend heavily on external support for antiretroviral treatment (ART), testing services and public awareness campaigns. Any reduction in funding risks service disruption, increased transmission and setbacks to national health goals. Donor-supported programs have included nationwide HIV awareness campaigns, voluntary counseling and testing services and integration of HIV services into primary health care, all of which have contributed to maintaining low prevalence levels. Here is why sustained funding matters.

Continuity of Treatment

HIV is a lifelong condition with no cure and requires continuous treatment with antiretroviral drugs to suppress the virus and protect the immune system. According to the World Health Organization (WHO), uninterrupted ART significantly reduces HIV-related deaths and prevents drug resistance. Funding interruptions can lead to medication shortages, treatment gaps and declining health outcomes. Sustained funding for HIV/AIDS in Comoros ensures consistent patient monitoring, reliable medication supply and effective long-term care.

In Comoros, antiretroviral treatments are largely financed internationally, particularly grants from the Global Fund. According to UNAIDS, this external supply creates challenges such as supply chain delays, limited laboratory capacity and difficulties to provide a consistent patient follow-up across the islands. Sustained funding for HIV/AIDS in Comoros ensures consistent patient monitoring, reliable medication supply and effective long-term care.

Prevention and Education

Prevention and education programs are critical to maintaining low HIV prevalence in Comoros. One major example is the national prevention of mother-to-child transmission (PMTCT) program, supported by international partners such as UNICEF and WHO, which provides testing, treatment and counseling to pregnant women living with HIV; as a result, HIV prevalence among pregnant women stands at an exceptionally low level and infants born to HIV-positive mothers have consistently tested HIV-negative under this initiative.

Existing initiatives include community-based awareness campaigns supported by UNAIDS and the Global Fund, HIV testing and counseling services and outreach programs targeting young people and women. International assistance has supplied critical testing equipment and strengthened health worker training, helping expand access to HIV information and services. These programs promote safe practices, reduce stigma and encourage early testing. Long-term funding allows these initiatives to operate consistently and expand into underserved communities, particularly in rural areas.

Strengthening Health Systems

Efforts are underway to broaden health system improvements in Comoros. Investments have supported clinic infrastructure, trained health care workers and strengthened disease surveillance systems. However, challenges remain, including shortages of medical staff, limited laboratory capacity and unequal access to care between urban and rural regions. These weaknesses increase vulnerability to HIV transmission and hinder treatment access.

In Comoros, HIV/AIDS-related investments have contributed to improved primary health facilities and health worker training, but the country continues to face shortages of medical personnel and limited diagnostic infrastructure, particularly outside urban areas. According to the World Bank, stronger health systems improve economic resilience and reduce poverty in developing countries.

Solution in Action: The Global Fund

Established in 2002, the Global Fund has played a key role in supporting HIV/AIDS programs in Comoros. The Global Fund is one of the main external financiers of HIV/AIDS programs in Comoros, supporting HIV treatment and prevention efforts in collaboration with national health authorities. By financing antiretroviral therapy, HIV testing and health system strengthening, the organization has expanded access to essential services.

According to the Global Fund, its investments support the delivery of HIV services across the country, demonstrating how sustained international funding strengthens national health capacity. In 2023, countries supported by the Global Fund reported that approximately 25 million people were on antiretroviral therapy, and 53.8 million HIV tests were conducted through its investments, reaching millions with prevention services. While these figures reflect global outcomes, they illustrate the scale of support provided to countries like Comoros.

Poverty and HIV/AIDS in Comoros

Poverty remains a significant challenge in Comoros, where a large portion of the population lives below the national poverty line. Using the international poverty line of $3.65 per day, about 39.5% of Comorians lived in poverty in 2023, reflecting persistent economic hardship that constrains access to essential services like health care, education and transportation. In Comoros, long distances to health facilities, high out-of-pocket costs for care and shortages of trained health workers make it difficult for poor households to obtain HIV testing and treatment services, contributing to health inequalities. People living in poverty are also more vulnerable to poor health outcomes due to malnutrition and limited medical access. Addressing HIV/AIDS through sustained funding helps reduce these inequalities and supports broader poverty reduction efforts.

The Role of International Support

International support remains vital to sustaining HIV/AIDS programs. Comoros participates in regional HIV response efforts coordinated by UNAIDS and partners, such as Indian Ocean Island forum meetings aimed at strengthening prevention and treatment planning, demonstrating the active role of international support in shaping the country’s HIV strategy. Donor countries and multilateral institutions help bridge funding gaps while the government gradually strengthens domestic health financing. Sustained funding aligns with global commitments to end AIDS as a public health threat by 2030 and ensures that small island developing states like Comoros are not left behind.

Conclusion

The fight against HIV/AIDS in Comoros is about securing long-term public health and economic stability. Sustained funding ensures uninterrupted treatment, effective prevention strategies and stronger health systems. Programs supported by the Global Fund and other international partners show that long-term investment expands access to ART, increases testing in rural communities and reduces health disparities. With predictable and sustained funding, Comoros can continue to maintain low HIV prevalence, improve health outcomes and support sustainable development.

– Numahaiseta Sillah Tunkara

Numahaiseta is based in Duisburg, Germany and focuses on Technology and Politics for The Borgen Project.

Photo: Flickr

, ,

How the Global Fund Is Addressing TB in India

Tuberculosis in IndiaThe Global Fund is a nonprofit organization founded in 2002. Since then, it has provided treatment to people with HIV, tuberculosis (TB) and malaria around the world. As of the Summer of 2024, the Fund has invested almost $10 billion in TB prevention and treatment for patients worldwide.

The Global Fund has integrated numerous services into primary health care systems that use innovative technologies, such as mobile health solutions, to improve patient tracking and adherence to treatment. Health professionals will use vans with technology like X-rays and diagnosis kits to provide free health treatments in the most remote locations. The Fund has vastly increased community access to medicines, testing and protective equipment like mosquito nets.

The Global Fund and India’s Close Collaboration

The Global Fund utilizes various strategies to combat TB in India, which reported 1.96 million cases or one-third of TB cases globally in 2021. The Fund has worked closely with the Indian government since 2006 and multiple local nongovernmental organizations (NGOs) to implement effective TB screening, treatment and prevention programs. The government of India, especially Prime Minister Narendra Modi, has shown immense support for the initiative to end TB in India by next year.

Success in Perspective

In 2012, the Indian government implemented a law requiring all diagnosed cases of TB to be reported to public health officials. This policy has successfully reduced the number of unreported cases plaguing the country. One untreated case can spread the disease to 15-20 people in a year. Due to the highly infectious nature of TB, it is crucial to catch cases as early as possible.

Furthermore, through its close collaboration with the Global Fund, India has transitioned from having the highest tuberculosis population to becoming an innovative supporter of global health. In 2019, India hosted the organization’s Sixth Replenishment Preparatory Meeting. Today, thanks to the efforts of the Global Fund, India can support other global health care organizations by serving as a primary source of low-cost pharmaceuticals.

JEET

The Joint Effort to Eliminate TB (JEET), a nonprofit organization, partners with the Global Fund and NGOs in India to improve access to diagnoses and treatments across all communities. JEET works closely with community health professionals and hospitals to promote sustainable solutions that will continue to benefit the population in the future. Indeed, by collaborating with various NGOs, including TB Alert India and the NGO TB Consortium India (NTC), the organization can reach the most at-risk populations and manage cases and outbreaks efficiently.

India is among the countries with the highest number of private health care providers. Between 2018 and 2020, JEET expanded the Patient-Provider Support Agency model in more than 100 districts across nine high-TB-risk states. This model ensures widespread access to TB treatment and patient support in the most vulnerable communities.

Impact of the Global Fund on Poverty

In 2023, the Global Fund provided treatment to more than 2.4 million people in India, improving life expectancy in low-income communities. As of 2022, the Fund has reduced TB-related deaths by 36% since beginning its work in various countries. Ultimately, TB has a profound impact on poverty levels and economic productivity in India, highlighting how successful TB control can lead to healthier communities, reduced health care costs and enhanced economic opportunities for affected populations.

Impacted individuals struggle on different levels throughout day-to-day life, making access to treatment life-changing for families reliant on working income. Furthermore, reducing the impact of TB on health care systems leaves more time, staff and funding to address other health issues in low-income communities.

– Lauren Sellman

Lauren is based in Rochester Hills, MI, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr

, ,

The Current State of HIV/AIDS in Algeria

HIV/AIDS in Algeria
HIV/AIDS is a significant health issue in Algeria, affecting thousands of lives. Despite efforts to combat it, the disease remains a challenge for the nation. 

The Prevalence

Algeria has seen an increase in HIV/AIDS cases over the last few years. According to UNAIDS, 26,000 Algerian children and adults were reported as living with HIV in 2023. Newly recorded cases of HIV in children and adults increased by 2,100 cases between 2022 and 2023. 

Early detection and treatment are crucial for managing the disease and preventing its spread. The government and non-governmental organizations work tirelessly to raise awareness and provide medical support to those affected.

Support Programs

The Algerian government has implemented several initiatives to combat HIV/AIDS. These programs, such as The Global Fund, focus on education, prevention, and treatment. Additionally, free antiretroviral therapy is available to patients, ensuring they receive the necessary medications to manage their condition effectively.

Non-governmental organizations (NGOs) also play a vital role in the fight against HIV/AIDS in Algeria. These organizations work at the grassroots level, providing education and support to communities.

They conduct workshops, distribute educational materials and offer counseling services to those affected by the disease. NGOs also collaborate with the government to implement nationwide awareness campaigns and improve access to health care services.

For example, The Kaiser Family Foundation is an NGO that focuses on various domestic and international health epidemics. This foundation specifically examines global health policies to better improve access to care for those living with HIV in the U.S. and overseas. 

The Impact of Stigma and Discrimination

Stigma and discrimination against people living with HIV/AIDS remain significant challenges in Algeria. Many individuals face social isolation and rejection due to their HIV status. This stigma often prevents them from seeking the medical help they need.

To address this issue, awareness campaigns aim to educate the public about HIV/AIDS and reduce the stigma associated with the disease. By fostering a more inclusive society, Algeria can better support those affected by HIV/AIDS.

Access to Health Care Services and Technology

Access to health care services is essential for managing HIV/AIDS in Algeria. The government has established numerous health care centers across the country to provide testing, treatment and counseling services.

These centers offer free and confidential HIV testing, which helps to make sure that individuals can receive a diagnosis without fear of discrimination. Additionally, trained health care workers provide compassionate and non-judgmental care to those living with HIV/AIDS.

Technology plays a crucial role in advancing HIV/AIDS research in Algeria. Labs use hot plate magnetic stirrers to achieve accurate results, which is particularly useful in the research of HIV/AIDS.

These devices ensure precise temperature control and consistent mixing, leading to more reliable data. By leveraging advanced technology, researchers can develop better treatment options and improve the overall understanding of the disease.

Community Support and Involvement

Support groups and community centers provide a safe space for people to share their experiences and seek emotional support. These groups also offer practical assistance, such as help with medication adherence and access to health care services. By fostering a strong sense of community, Algeria can better support those affected by HIV/AIDS and improve their quality of life.

The fight against HIV/AIDS in Algeria requires a multifaceted approach. By addressing the stigma, improving education, and leveraging technology, the country can better support those affected by the disease. Continued efforts and collaboration are necessary for making progress in this ongoing battle.

– Kelly Schoessling

Kelly focuses on World News for The Borgen Project.

Photo: Flickr

, ,

How the Global Fund Is Fighting HIV/AIDS

The Global FundThe Global Fund is a “Global Health Partnership” that receives funds from different sources, including the private sector, foundations and governments, to fight human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), Malaria and Tuberculosis. The partnership was established in 2002 and has saved 59 million lives by investing more than $60 billion in global health care systems to help ensure equal access to care across the world. The Fund’s HIV/AIDS goals include, but are not limited to, fulfilling the World Health Organization’s “Treat All” guidance and the United States Agency for International Development’s (USAID) 95-95-95 strategy.

What Is HIV/AIDS?

HIV is a virus that damages a person’s immune system, making them more susceptible to infections and other diseases. AIDS, on the other hand, is used to describe the often life-threatening infections and illnesses that occur after damage to the immune system has been caused by HIV.

HIV can be contracted by anyone through the body fluids of an infected person, through unprotected sex, sharing needles or transmission from mother to baby (via pregnancy, birth or breastfeeding). When discussing these interrelated terms, it is important to note that while HIV can be transmitted, AIDS cannot be.

With HIV treatment, “most people” can be prevented from developing AIDS-related illnesses and can get to the point of having an “undetectable viral load.”

WHO’s Treat All Guidance and USAID’s 95-95-95 Strategy

HIV is a global health care problem and as such, global organizations have set strategies in place. In 2016, the WHO launched the “Treat All” plan to tackle the number of people living with HIV, where it recommended that “all people living with HIV be provided with antiretroviral therapy (ART)” with the aim of reaching all 37 million with the virus.

Furthermore, USAID has set out another global strategy. Its 95-95-95 strategy is an HIV plan that has the following aims for 2025:

  • 95% of women in their reproductive years receive comprehensive HIV and sexual and reproductive health services.
  • 95% of pregnant and breastfeeding women diagnosed with HIV achieve viral load suppression.
  • 95% of children born to HIV-positive mothers undergo testing for potential exposure to the virus.

The Global Fund says it is “making significant progress” toward fulfilling both the WHO and USAID guidance.

Key Populations and Why They Matter

The WHO defines a key population as a group that “frequently face legal and social challenges that increase their vulnerability to HIV, including barriers to accessing HIV prevention, treatment and other health and social services.” According to USAID, 70% of new HIV infections occur in key populations and can go unresolved due to factors like stigma, human rights violations and violence.

The Global Fund has found that due to COVID-19, progress in the prevention and treatment of HIV/AIDs was reduced, with key populations being left behind, including children, adolescent girls and young women. For instance, there is a high disparity in care between children and adults, with 43% of HIV-positive children being unable to access lifesaving treatment compared to 23% of HIV-positive adults. Targeted health care tailored to these populations is crucial. Failure to address their infection rates undermines the long-term goal of eradicating HIV and AIDS.

What Has the Global Fund Done?

So far, the Global Fund has invested more than $25.5 billion in global HIV/AIDS care, providing more than a quarter of all international financing for this disease. Furthermore, in 2022, the organization provided antiretrovirals for 24.5 million people. In the same year, more than 15 million people, including 710,000 HIV-positive expectant mothers, received preventative care as a result of the partnership.

In fact, in the countries where it provided care, 82% of mothers were able to prevent the spreading of HIV to their babies. Moreover, due to the high number of HIV tests carried out, 53.1 million, the Global Fund was able to create a 72% reduction in AIDS-related deaths in countries where it operates.

The partnership has also identified 13 countries that have been made a priority, where key populations such as young women and adolescent girls are specifically targeted to benefit from HIV prevention programs. This is because they are “more than three times as likely” to contract HIV than their male counterparts.

Looking Ahead

In July 2021, the Global Fund released its 2023-2028 strategy, a continuation of all the work that it has done so far to improve health care outcomes globally. Its mission is officially to “To attract, leverage and invest additional resources to end the epidemics of HIV, tuberculosis and malaria, reduce health inequities and support attainment of the Sustainable Development Goals.” Ultimately, it aims to create a world that is healthier and better for all.

– Rachael Denton-Snape

Rachael is based in High Wycombe, UK and focuses on Global Health for The Borgen Project.

Photo: Flickr

,

How Foreign Aid Is Addressing Tuberculosis in Tajikistan

 

Tuberculosis in TajikistanThe landlocked country of Tajikistan has for years had one of the worst rates of drug-resistant tuberculosis (TB) cases anywhere in the world. Now, foreign aid to Tajikistan is helping to alleviate the country’s health burden.

A History of Tuberculosis Struggle in Tajikistan

Poverty is an influential determinant of TB. Poor living and working conditions directly increase the risk of transmission among people. For decades Tajikistan has had one of the worst rates of infection and TB mortality of any Central Asian country. However, a brief look at these rates offers signs of a promising future.

In 2002, the reported rate of TB per 100,000 people was 219. An encouraging downward trend saw the rate drop to 82 in 2019. This decrease in infection rates could be due to new successful treatments of the disease. By the time of recording in 2019, 91% of cases had been treated successfully, according to The Global Fund. Despite making significant progress in the past two decades, Tajikistan remains ranked 23rd out of the drug-resistant tuberculosis countries throughout the world.

The Front Line

Since 2011, Zufliya Dusmatova has worked for Médecins Sans Frontières (MSF) in Tajikistan as part of a program that focuses on pediatric TB. She knows all too well how hard the battle against the disease is in this part of the world. “Children have different symptoms of TB than adults…the symptoms in children often resemble other diseases and therefore pediatricians might treat children for viruses or diseases, like a cold or bronchitis,” she explained.

A considerable barrier to accurate diagnosis is the expense of CT scans in the region. Without the aid of life-saving equipment stopping the transference and growth of TB within patients can lead to death. Furthermore, the social stigma associated with the disease presents a further challenge to caregivers as those suffering from TB are less likely to seek treatment should it affect employment opportunities or even marriage prospects, MSF reports.

The World Health Organization (WHO) has since consolidated guidelines on drug-resistant TB treatment, doing much to help and identify those suffering from TB in Tajikistan, according to MSF.

Foreign Aid to Tajikistan

Foreign aid to Tajikistan is vital in the fight back against diseases like TB. As a low-income country largely reliant on labor remittances, any economic shock can be disastrous for health care initiatives in Tajikistan. This is why in 2020 state aid to Tajikistan from the U.S. continued to support the fight. The $51.3 million assistance, not including an additional $6.3 million for COVID-19 assistance, is essential in continuing to safeguard Tajikistan’s national health.

Furthermore, in 2021, USAID donated TB detection equipment to Tajikistan’s Ministry of Health. The equipment included smartphones, tablets, video conferencing devices and equipment for climate control.

In addition to U.S. support, the World Bank has agreed to support the new Tajikistan Millati Solim (Health Nation) project with $57.25 million. The project and funding will support improvements in primary health care services throughout the country. As well as to better prepare Tajikistan for any future health care emergencies.

A Brighter Future

The past two decades have seen many successes in Tajikistan’s battle to control TB infection within the country. However, that fight is not over. On March 24, 2023, the UNDP reaffirmed its commitment to eradicating TB in Tajikistan by celebrating World TB Day. The day’s theme of “Yes! We can end TB!” both provides hope for Tajikistan’s future and a reminder of how far the nation has come.

– Thomas Field
Photo: Flickr

Combating HIV/AIDS in Madagascar

HIV/AIDS in MadagascarThe number of people dying from AIDS in Madagascar increased by a staggering 480% from 2010 to 2021. Madagascar is an island nation in the Indian Ocean off the southeast coast of Africa and is home to 28 million people. An estimated 70,000 people lived with HIV in Madagascar in 2022, 5,000 of whom were children under 14. Analysts warn that there is a lack of sufficient data on HIV in Madagascar and caution that actual rates of infection may be higher than estimates. Combating HIV/AIDS in Madagascar is a significant challenge, and organizations actively work to provide relief to those impacted.

Obstacles to HIV Testing and Treatment

The fight against HIV in Madagascar faces formidable challenges. As citizens contend with rising rates of HIV/AIDS, they also face extreme levels of poverty. Many people do not have access to clean water, shelter or education. The World Bank reports that 75% of people in Madagascar live below the national poverty line. Madagascar has an ineffective government and a weak economy. In 2008, a coup d’état heavily disrupted the country’s health programs and foreign aid. 

The provisional government proved unable to enact effective HIV prevention or treatment strategies. The COVID-19 pandemic, as well as natural disasters, heightened the number of people experiencing poverty in Madagascar. Most recently, the country suffered from drought from 2018 to 2022 and Cyclone Freddy in February 2023. These factors create a challenging backdrop to thwart HIV/AIDS.

In an audit from 2019 to 2021, The Global Fund cited the availability of HIV test kits as a challenge. Testing supplies are often out of stock, and without access, many citizens are unaware of their status. Additionally, maintaining suitable storage conditions for health products, like HIV medication, is difficult. There is limited access to HIV treatment, and less than 1% of health care sites in Madagascar provide antiretroviral treatment. Current policy dictates that citizens procure HIV treatment through the government, decreasing access.

Humanitarian Efforts Drive Improvements

Global humanitarian organizations continually search for ways to address challenges and combat HIV/AIDS in Madagascar. While there is significant room for improvement, aid organizations made notable contributions in recent years.

Since 2005, The Global Fund has provided $72 million in HIV/AIDS relief to Madagascar and supplied free antiretroviral therapy. The organization recently reported an increase in the number of people receiving HIV treatment. In 2018, 3,510 people received HIV treatment, while in 2021, 8,995 people received HIV treatment. The number of people with HIV who were aware of their status increased by 73% from 2018 to 2021. Additionally, The Global Fund confirmed a reliable pipeline from HIV testing to treatment for citizens of Madagascar. More than 95% of people who tested positive for HIV received treatment. In an investigation, The Global Fund found that antiretroviral treatments were in stock and available to citizens.

The United States Agency for International Development (USAID) also provides relief for the people of Madagascar. The organization gave more than $130 million in 2020, of which $74.5 million went to health services. USAID invests in the prevention of HIV/AIDS and primary health care in Madagascar, among other directives. In October 2023, USAID gave computer equipment to Madagascar to manage health information. This equipment will synthesize data to aid in the improvement of citizens’ health. 

Going Forward

Tackling HIV/AIDS in Madagascar presents significant difficulties. Providing effective HIV/AIDS testing and treatment is challenging due to widespread poverty and a weak government. Organizations are actively working through these challenges to improve the state of HIV/AIDS in the country. Investments in the prevention of HIV/AIDS and increases in the number of people who know their HIV status provide a starting point for further improvements.

– Kelly Carroll
Photo: Flickr

Contributions of The Gates Foundation To Tackle HIV/AIDS

The Gates Foundation
Bill Gates and his ex-wife Melinda French are two of the most prominent and generous philanthropists in the world. In 2000, they set up the Gates Foundation, an organization dedicated to alleviating a variety of social ailments, including global poverty and disease. Since its founding, the Foundation has invested an unprecedented $79.2 billion towards this goal, with $39 billion of that coming from Bill and Melinda themselves. Today, the Foundation is one of the most powerful and influential nonprofits in the world. 

HIV/AIDS has ravaged vulnerable countries and societies since the 1980s, with the epidemic killing an estimated 40 million people since it was first discovered. Like many other nonprofits, the Gates Foundation has dedicated much of its research, volunteering and funding to tackling the epidemic. This ultimately helps the poorest and most vulnerable people across the world who are most at risk of becoming infected with HIV. 

Assisting the Global Fund

One of the main ways that the Gates Foundation is tackling HIV/AIDS is by supplying direct funding to The Global Fund to Fight AIDS, tuberculosis and malaria, an organization established by the United Nations in 2002 with the ultimate goal of removing those three diseases from the world. In fact, The Gates Foundation provided the seed money for the Fund when it was first established, making Gates and French crucial stakeholders in the organization. 

The Gates Foundation continues to make regular financial commitments to the Global Fund, particularly because of its work fighting HIV and AIDS. Over the course of 25 months between 2020 and 2022, the Foundation pledged more than $731 million for the Fund, with Gates himself calling the Fund “one of the most effective ways we invest our money every year.” Gates’ continuous support of the Global Fund allows the institution to continue its vital work, saving an estimated 100,000 lives a month through the provision of antiretroviral treatment and other forms of medication. 

By working in collaboration with The Global Fund, The Gates Foundation is an extremely significant instrument that is used to tackle HIV/AIDS, not just by funding the supply of medicinal supplies, but also through the financing of research on the diseases. By Gates’ own admission, treatment without prevention is entirely “unsustainable,” meaning that The Gates Foundation also uses The Global Fund to research microbicides and other preventative measures to stop the spread of HIV. 

Tackling the Stigma of HIV/AIDS 

In addition to providing financial support to The Global Fund, the Gates Foundation is also tackling HIV/AIDS by fighting the harsh stigma that surrounds the disease that prevents people from seeking and receiving the help that they so desperately need. 

Since the discovery of AIDS in 1981 and HIV in 1984, there has been a large, albeit reduced, fear of the disease and of its transmission. Thousands of people have died of AIDS as a result of this stigma in both developed and developing countries, which governments across the world largely ignored. The Gates Foundation has recently called for greater access to preventative HIV measures that reduce transmission rates dramatically, and has also called upon governments and NGOs to join them in breaking the stigma. 

The Gates Foundation acknowledges that researching and providing treatment for HIV/AIDS is a challenge in itself, with its difficulty being exacerbated by public opinion of the disease. Melinda French has publicly spoken out about the difficulty she faced trying to speak to sex workers who help fight HIV/AIDS during her travels around the world doing charity work on behalf of the Foundation, calling for greater advocacy to remove the stigma entirely. 

While there are an innumerable number of organizations, charities and government policies dedicated to tackling HIV/AIDS in 2023, the Gates Foundation’s resources, influence and longevity have made it one of the most effective institutions that prioritizes fighting the disease. Through a combination of funding vital research and allocation of medicine, and fighting the cruel stigma of the diseases, the Gates Foundation is making major contributions to tackling HIV/AIDS and has done so for many years.

– Tom Lowe
Photo: Flickr

A Closer Look at HIV/AIDS in Somalia

HIV/AIDS in SomaliaSomalia, a large country nestled in the Horn of Africa, is one of many developing countries affected by the AIDS epidemic, though not to the extent of other areas within sub-Saharan Africa. Though Somalia notes a relatively low prevalence rate of HIV/AIDS at 0.10% in 2022, organizations are working on further progress in the area of HIV/AIDS in Somalia.

HIV/AIDS in Somalia in Numbers

When the epidemic began in Somalia in 1990, an estimated 2,500 Somali people lived with HIV. This number reached a peak of 15,000 in 2005. However, since then, incidents of  HIV/AIDS in Somalia have steadily reduced. In 2021, an estimated 7,700 people lived with HIV/AIDS in Somalia, according to data from UNAIDS. In terms of gender, HIV/AIDS impacts more women than men. In 2021, women accounted for 52% of people 15 and older living with the condition in Somalia. Young women are more likely than men to contract a new HIV infection as they are more likely to face gender-based violence and are more harshly impacted by poverty and inequality. However, Somalia notes an equal split in the number of AIDS-related deaths according to gender.

The Impact of Poverty and Stigma

Close to 70% of Somali people are living below the poverty line, according to 2022 statistics. The decades-long war and severe weather conditions have contributed to both poverty and food insecurity. Living in poverty can be a catalyst for contracting HIV. Similarly, contracting HIV can deepen already existing poverty.

Conditions of poverty can lead to risky behaviors such as participating in transactional sex for food or shelter. Poverty is also a risk factor for developing unhealthy behaviors such as substance abuse, which lowers the chance of taking precautionary measures to protect against HIV. Improper drug use, such as the reusing of contaminated needles, can also cause HIV.

Additionally, the health care system in Somalia is poor. As of 2020, the existing health care system within Somalia is largely privatized. This means that impoverished Somalis, especially those living in rural areas, do not have access to affordable health care. In fact, estimates indicate that less than 30% of Somali people have access to health care.

The stigma and shame surrounding HIV/AIDS serve as a barrier to testing, diagnosis and treatment. People living with HIV experience discrimination and alienation not just from society but also from health care workers. For this reason, people are reluctant to utilize HIV services and visit clinics/hospitals. Oftentimes, people living with HIV “…only [became] aware of their HIV-positive status” when their partner received a positive diagnosis or “when the individual fell ill and all other attempts at healing them did not work,” according to a research study by Abdulwahab M. Salad and others published online in 2022.

Solutions to Addressing HIV/AIDS in Somalia

Within Somalia, the World Health Organization (WHO) focuses on addressing the epidemic by ensuring greater access to ART drugs, HIV testing and counseling. The WHO states that “Somalia is holding its own in comparison with immediate neighbors and other countries in the region” and that by the end of December 2022, 4,100 patients across Somalia were receiving antiretroviral therapy with the help of the WHO.

The WHO works in Somalia alongside the Global Fund. The Global Fund provided an investment of $18.6 million for the period of 2021 to 2023 to strengthen the HIV response in Somalia. This investment aims to “support Somalia in its goals of accelerating progress toward 95-95-95 HIV testing and treatment targets, reducing new HIV cases, mortality and morbidity by 30% and significantly reducing HIV-related discrimination in health care settings,” the Global Fund website says.

Visible Progress

Indeed, progress is visible as the Somali HIV National Strategic Plan states “…projected rates of new HIV infections dropped significantly from year 2000 to 2010 with numbers plateauing from 2012 to date. The early decline of new infections could be attributed to the strong cultural drive as well as heightened prevention interventions.”

Due to Somalia’s progression in reducing the HIV/AIDS prevalence rate from more than 1% in 2013 to 0.10% in 2022, Somalia maintains its status as “a low-level HIV epidemic country” as classified in 2014. Overall, Somalia is making significant progress as AIDS-related deaths are steadily declining and ART coverage rates are increasing, UNAIDS data shows.

But, it is imperative to continue advocating in other areas, such as poverty and stigma reduction, education, safe sex and drug use harm reduction for these numbers to continue dropping and to fully eradicate HIV/AIDS within Somalia.

– Chloe Jenkins
Photo: Flickr

HIV/AIDS in Honduras

HIVAIDS in Honduras
With a population of more than 10 million, Honduras is the second-largest country in Central America but it has the highest prevalence of HIV/AIDS cases in the region. Since its first cases in 1985, the disease has quickly become an epidemic, causing up to 1,000 deaths per year and leaving as many as 16,000 orphans as of 2021.

Reasons for High HIV/AIDS Rates

The spread of HIV/AIDS in Honduras is largely due to a lack of awareness, education and health care. USAID reports that only 65% of women reported using condoms as a preventative measure and 90% of women faced at least one obstacle in accessing health care. More than half a decade later, in 2012, only 61% of individuals reported having used a condom during their last sexual encounter with a high HIV-risk partner and 32% used this protection the last time they paid for sex. Just 57% of HIV-positive individuals were aware of their condition, according to a 2021 report. Delayed detection and lack of treatment allow the disease to spread, often unnoticed, through communities, via intercourse, mother-to-child transmission and infected blood.

The Effects of HIV/AIDS

HIV/AIDS is primarily dangerous for its weakening of the immune system, making the carrier vulnerable to other infectious diseases, such as tuberculosis (TB), one of the main causes of death of HIV carriers in Honduras. Approximately 13% of TB patients in Honduras have HIV, according to USAID.

After diagnosis, carriers often face stigmatization and discrimination from their community. The 2005–2006 Honduras Demographic and Health Survey (DHS) showed that only 46% of women would buy produce from an HIV-positive vendor and only 56% believed an infected teacher should be able to continue his profession. Unemployment and poverty further marginalize these individuals, USAID reports. As three-quarters of HIV infections in Honduras occur in its most economically active population, the age group of 20 to 39, the economic growth of communities and the nation as a whole is impeded.

In some cases, HIV/AIDS infections have led to human rights abuses in the form of involuntary sterilization. A 2018 City University of New York (CUNY) research study presented the case studies of two women seeking asylum in the U.S. to avoid sterilization on the basis of their diagnosis.

The Most Affected

Higher rates of HIV/AIDS exist among Honduras’ more vulnerable communities, such as female sex workers, gay men and Garífuna communities. Although neither homosexuality nor sex work is illegal, both communities report regular harassment and stigmatization and these disadvantages are subsequently amplified upon diagnosis, according to The Global Fund report.

The Afro-indigenous ethnic group, the Garífuna, reported a rate of HIV infections “over three times the national average,” largely because of the high levels of migration which facilitates sexual concurrency and the risk of contracting a sexually transmitted infection (STI).

Efforts to Fight the Epidemic

Internal and external efforts to combat HIV/AIDS in Honduras have shown consistently positive results. Plans have primarily focused on promoting education surrounding sexual and reproductive health, expanding STI treatment and prevention, providing access to antiretroviral therapy (ART) and increasing surveillance and research. HIV/AIDS incidence has fallen from 0.7% in 2007, according to USAID, to 0.2% in 2021. AIDS-related deaths also fell from 40 per 100,000 in 2002 to 7 per 100,000 in 2020.

The PEPFAR provided AIDS-related support to more than 30,000 Hondurans in 2022 alone and identified 1,190 undiagnosed individuals, who were then able to seek treatment. The nonprofit organization Project HOPE has worked in Honduras since 1984 to support the eradication of HIV/AIDS-related deaths. This progress is ongoing.

Additionally, The Global Fund recently achieved a U.S. grant of up to $19.1 million for Honduras for 2022-2025. Its aims include reducing deaths from AIDS-related causes by 50% and reducing HIV prevalence among men who have sex with men to 5% or lower.

The Future

There is still far to go in the fight against HIV/AIDS in Honduras and unforeseen challenges such as natural disasters and the COVID-19 pandemic threatens disruption to HIV/AIDS treatments and preventative programs. Nevertheless, progress is visible and ongoing. Improved access to critical treatment means a diagnosis is no longer a death sentence.
 
– Helene Schlichter
Photo: Pixabay